Basic Information
RELENZA ROTADISK 5 mg/dose
POWDER, METERED
Regulatory Information
SIN11199P
October 21, 1999
Prescription Only
Therapeutic
RESPIRATORY (INHALATION)
August 10, 2023
June 3, 2025
XJ05AH01
Company Information
GLAXOSMITHKLINE PTE LTD
GLAXOSMITHKLINE PTE LTD
Active Ingredients
Strength: 5 mg/dose
Detailed Information
Contraindications
**Contra-indications** Hypersensitivity to any ingredient of the preparation (see Pharmaceutical Particulars – List of Excipients – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Contraindicated in patients with severe milk protein allergy.
Indication Information
**Indications** Treatment of Influenza: Relenza is indicated for treatment of infections due to influenza A and B viruses in adults and children 5 years and older. Prophylaxis: Relenza is indicated for prophylaxis of both influenza A and B in adults and juveniles 12 years and older.